The intricate interplay between RNA viruses and NF-κB

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 11, 2014, Pages 2754-2764

  Schmitz, M Lienhard ^a   Kracht, Michael ^b   Saul, Vera V ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

Influenza virus; Interferon signaling; NF B; RNA virus; Signal transduction

Indexed keywords

ANTIVIRUS AGENT; INFLAMMASOME; OLIGOMER; PRION PROTEIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; RETINOIC ACID INDUCIBLE PROTEIN I; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

GENETIC VARIABILITY; GENOME; HOST CELL; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA VIRUS; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 84940233721     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.08.004     Document Type: Review

References (162)

1. Baltimore D. Expression of animal virus genomes. Bacteriol. Rev. 1971, 35:235-241.
2. Domingo E., Holland J.J. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 1997, 51:151-178.
3. Drake J.W., Holland J.J. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:13910-13913.
4. Kash J.C., Tumpey T.M., Proll S.C., Carter V., Perwitasari O., Thomas M.J., Basler C.F., Palese P., Taubenberger J.K., Garcia-Sastre A., Swayne D.E., Katze M.G. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 2006, 443:578-581.
5. Garcia-Sastre A., Biron C.A. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 2006, 312:879-882.
6. Stetson D.B., Medzhitov R. Type I interferons in host defense. Immunity 2006, 25:373-381.
7. Haller O., Kochs G., Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006, 344:119-130.
8. Zeng W., Sun L., Jiang X., Chen X., Hou F., Adhikari A., Xu M., Chen Z.J. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 2010, 141:315-330.
9. Cai X., Chen J., Xu H., Liu S., Jiang Q.X., Halfmann R., Chen Z.J. Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 2014, 156:1207-1222.
10. Hou F., Sun L., Zheng H., Skaug B., Jiang Q.X., Chen Z.J. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011, 146:448-461.
11. Lu A., Magupalli V.G., Ruan J., Yin Q., Atianand M.K., Vos M.R., Schroder G.F., Fitzgerald K.A., Wu H., Egelman E.H. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 2014, 156:1193-1206.
12. Patel J.R., Jain A., Chou Y.Y., Baum A., Ha T., Garcia-Sastre A. ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon. EMBO Rep. 2013, 14:780-787.
13. Peisley A., Wu B., Yao H., Walz T., Hur S. RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. Mol. Cell 2013, 51:573-583.
14. Le B.A., Tough D.F. Type I interferon as a stimulus for cross-priming. Cytokine Growth Factor Rev. 2008, 19:33-40.
15. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
16. Diebold S.S., Kaisho T., Hemmi H., Akira S., Reis e Sousa Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
17. Schulz O., Diebold S.S., Chen M., Naslund T.I., Nolte M.A., Alexopoulou L., Azuma Y.T., Flavell R.A., Liljestrom P., Reis e Sousa Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 2005, 433:887-892.
18. Kariko K., Ni H., Capodici J., Lamphier M., Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J. Biol. Chem. 2004, 279:12542-12550.
19. Liu L., Botos I., Wang Y., Leonard J.N., Shiloach J., Segal D.M., Davies D.R. Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 2008, 320:379-381.
20. Diebold S.S., Massacrier C., Akira S., Paturel C., Morel Y., Reis e Sousa Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Eur. J. Immunol. 2006, 36:3256-3267.
21. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
22. Seo S.U., Kwon H.J., Song J.H., Byun Y.H., Seong B.L., Kawai T., Akira S., Kweon M.N. MyD88 signaling is indispensable for primary influenza A virus infection but dispensable for secondary infection. J. Virol. 2010, 84:12713-12722.
23. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., Yamaguchi O., Otsu K., Tsujimura T., Koh C.S., Reis e Sousa, Matsuura Y., Fujita T., Akira S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
24. Vitour D., Meurs E.F. Regulation of interferon production by RIG-I and LGP2: a lesson in self-control. Sci. STKE 2007, 2007:e20.
25. Hornung V., Ellegast J., Kim S., Brzozka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., Endres S., Hartmann G. 5'-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314:994-997.
26. Schlee M., Roth A., Hornung V., Hagmann C.A., Wimmenauer V., Barchet W., Coch C., Janke M., Mihailovic A., Wardle G., Juranek S., Kato H., Kawai T., Poeck H., Fitzgerald K.A., Takeuchi O., Akira S., Tuschl T., Latz E., Ludwig J., Hartmann G. Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 2009, 31:25-34.
27. Kowalinski E., Lunardi T., McCarthy A.A., Louber J., Brunel J., Grigorov B., Gerlier D., Cusack S. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 2011, 147:423-435.
28. Peisley A., Wu B., Xu H., Chen Z.J., Hur S. Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. Nature 2014, 509:110-114.
29. Peisley A., Jo M.H., Lin C., Wu B., Orme-Johnson M., Walz T., Hohng S., Hur S. Kinetic mechanism for viral dsRNA length discrimination by MDA5 filaments. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E3340-E3349.
30. Wu B., Peisley A., Richards C., Yao H., Zeng X., Lin C., Chu F., Walz T., Hur S. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 2013, 152:276-289.
31. Zhu Z., Zhang X., Wang G., Zheng H. The laboratory of genetics and physiology 2: emerging insights into the controversial functions of this RIG-I-like receptor. Biomed. Res. Int. 2014, 2014:960190.
32. Rathinam V.A., Fitzgerald K.A. Cytosolic surveillance and antiviral immunity. Curr. Opin. Virol. 2011, 1:455-462.
33. Garbelli A., Beermann S., Di C.G., Dietrich U., Maga G. A motif unique to the human DEAD-box protein DDX3 is important for nucleic acid binding, ATP hydrolysis, RNA/DNA unwinding and HIV-1 replication. PLoS One 2011, 6:e19810.
34. Cruciat C.M., Dolde C., de Groot R.E., Ohkawara B., Reinhard C., Korswagen H.C., Niehrs C. RNA helicase DDX3 is a regulatory subunit of casein kinase 1 in Wnt-beta-catenin signaling. Science 2013, 339:1436-1441.
35. Oshiumi H., Sakai K., Matsumoto M., Seya T. DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential. Eur. J. Immunol. 2010, 40:940-948.
36. Zhang J., Hu M.M., Wang Y.Y., Shu H.B. TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63-linked ubiquitination. J. Biol. Chem. 2012, 287:28646-28655.
37. Zhang Z., Kim T., Bao M., Facchinetti V., Jung S.Y., Ghaffari A.A., Qin J., Cheng G., Liu Y.J. DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells. Immunity 2011, 34:866-878.
38. Dixit E., Boulant S., Zhang Y., Lee A.S., Odendall C., Shum B., Hacohen N., Chen Z.J., Whelan S.P., Fransen M., Nibert M.L., Superti-Furga G., Kagan J.C. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 2010, 141:668-681.
39. van Zuylen W.J., Doyon P., Clement J.F., Khan K.A., D'Ambrosio L.M., Do F., St-Amant-Verret M., Wissanji T., Emery G., Gingras A.C., Meloche S., Servant M.J. Proteomic profiling of the TRAF3 interactome network reveals a new role for the ER-to-Golgi transport compartments in innate immunity. PLoS Pathog. 2012, 8:e1002747.
40. Liu S., Chen J., Cai X., Wu J., Chen X., Wu Y.T., Sun L., Chen Z.J. MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. Elife 2013, 2:e00785.
41. Hayden M.S., Ghosh S. NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012, 26:203-234.
42. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003, 4:491-496.
43. Larabi A., Devos J.M., Ng S.L., Nanao M.H., Round A., Maniatis T., Panne D. Crystal structure and mechanism of activation of TANK-binding kinase 1. Cell Rep. 2013, 3:734-746.
44. Oganesyan G., Saha S.K., Guo B., He J.Q., Shahangian A., Zarnegar B., Perry A., Cheng G. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 2006, 439:208-211.
45. Tu D., Zhu Z., Zhou A.Y., Yun C.H., Lee K.E., Toms A.V., Li Y., Dunn G.P., Chan E., Thai T., Yang S., Ficarro S.B., Marto J.A., Jeon H., Hahn W.C., Barbie D.A., Eck M.J. Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Rep. 2013, 3:747-758.
46. Tamura T., Yanai H., Savitsky D., Taniguchi T. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 2008, 26:535-584.
47. Panne D., Maniatis T., Harrison S.C. An atomic model of the interferon-beta enhanceosome. Cell 2007, 129:1111-1123.
48. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 2002, 10:417-426.
49. Rathinam V.A., Fitzgerald K.A. Inflammasomes and anti-viral immunity. J. Clin. Immunol. 2010, 30:632-637.
50. Allen I.C., Scull M.A., Moore C.B., Holl E.K., McElvania-TeKippe E., Taxman D.J., Guthrie E.H., Pickles R.J., Ting J.P. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009, 30:556-565.
51. Thomas P.G., Dash P., Aldridge J.R., Ellebedy A.H., Reynolds C., Funk A.J., Martin W.J., Lamkanfi M., Webby R.J., Boyd K.L., Doherty P.C., Kanneganti T.D. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 2009, 30:566-575.
52. Poeck H., Bscheider M., Gross O., Finger K., Roth S., Rebsamen M., Hannesschlager N., Schlee M., Rothenfusser S., Barchet W., Kato H., Akira S., Inoue S., Endres S., Peschel C., Hartmann G., Hornung V., Ruland J. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat. Immunol. 2010, 11:63-69.
53. Park S., Juliana C., Hong S., Datta P., Hwang I., Fernandes-Alnemri T., Yu J.W., Alnemri E.S. The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity. J. Immunol. 2013, 191:4358-4366.
54. Subramanian N., Natarajan K., Clatworthy M.R., Wang Z., Germain R.N. The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation. Cell 2013, 153:348-361.
55. Belgnaoui S.M., Paz S., Hiscott J. Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr. Opin. Immunol. 2011, 23:564-572.
56. Hinz M., Scheidereit C. The IkappaB kinase complex in NF-kappaB regulation and beyond. EMBO Rep. 2014, 15:46-61.
57. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., Chen Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001, 412:346-351.
58. Li Z.W., Chu W., Hu Y., Delhase M., Deerinck T., Ellisman M., Johnson R., Karin M. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J. Exp. Med. 1999, 189:1839-1845.
59. Chariot A. The NF-kappaB-independent functions of IKK subunits in immunity and cancer. Trends Cell Biol. 2009, 19:404-413.
60. Scheidereit C. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 2006, 25:6685-6705.
61. Oeckinghaus A., Hayden M.S., Ghosh S. Crosstalk in NF-kappaB signaling pathways. Nat. Immunol. 2011, 12:695-708.
62. Razani B., Reichardt A.D., Cheng G. Non-canonical NF-kappaB signaling activation and regulation: principles and perspectives. Immunol. Rev. 2011, 244:44-54.
63. Senftleben U., Cao Y., Xiao G., Greten F.R., Krahn G., Bonizzi G., Chen Y., Hu Y., Fong A., Sun S.C., Karin M. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 2001, 293:1495-1499.
64. Amir R.E., Haecker H., Karin M., Ciechanover A. Mechanism of processing of the NF-kappa B2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCF(beta-TrCP) ubiquitin ligase. Oncogene 2004, 23:2540-2547.
65. Fong A., Zhang M., Neely J., Sun S.C. S9, a 19S proteasome subunit interacting with ubiquitinated NF-kappaB2/p100. J. Biol. Chem. 2002, 277:40697-40702.
66. Bonizzi G., Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25:280-288.
67. Stilmann M., Hinz M., Arslan S.C., Zimmer A., Schreiber V., Scheidereit C. A nuclear poly(ADP-ribose)-dependent signalosome confers DNA damage-induced IkappaB kinase activation. Mol. Cell 2009, 36:365-378.
68. Mabb A.M., Wuerzberger-Davis S.M., Miyamoto S. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. Nat. Cell Biol. 2006, 8:986-993.
69. Huang T.T., Wuerzberger-Davis S.M., Wu Z.H., Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 2003, 115:565-576.
70. Hinz M., Stilmann M., Arslan S.C., Khanna K.K., Dittmar G., Scheidereit C. A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-kappaB activation. Mol. Cell 2010, 40:63-74.
71. McCool K.W., Miyamoto S. DNA damage-dependent NF-kappaB activation: NEMO turns nuclear signaling inside out. Immunol. Rev. 2012, 246:311-326.
72. Renner F., Moreno R., Schmitz M.L. SUMOylation-dependent localization of IKKepsilon in PML nuclear bodies is essential for protection against DNA-damage-triggered cell death. Mol. Cell 2010, 37:503-515.
73. Ziesche E., Kettner-Buhrow D., Weber A., Wittwer T., Jurida L., Soelch J., Muller H., Newel D., Kronich P., Schneider H., Dittrich-Breiholz O., Bhaskara S., Hiebert S.W., Hottiger M.O., Li H., Burstein E., Schmitz M.L., Kracht M. The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-kappaB. Nucleic Acids Res. 2013, 41:90-109.
74. Kawakami K., Scheidereit C., Roeder R.G. Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:4700-4704.
75. Sambucetti L.C., Cherrington J.M., Wilkinson G.W., Mocarski E.S. NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 1989, 8:4251-4258.
76. Julkunen I., Melen K., Nyqvist M., Pirhonen J., Sareneva T., Matikainen S. Inflammatory responses in influenza A virus infection. Vaccine 2000, 19(Suppl. 1):S32-S37.
77. Barrett T., Wolstenholme A.J., Mahy B.W. Transcription and replication of influenza virus RNA. Virology 1979, 98:211-225.
78. McGeoch D., Fellner P., Newton C. Influenza virus genome consists of eight distinct RNA species. Proc. Natl. Acad. Sci. U. S. A. 1976, 73:3045-3049.
79. Pahl H.L., Baeuerle P.A. Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B. J. Virol. 1995, 69:1480-1484.
80. Wang X., Li M., Zheng H., Muster T., Palese P., Beg A.A., Garcia-Sastre A. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J. Virol. 2000, 74:11566-11573.
81. Ehrhardt C., Ruckle A., Hrincius E.R., Haasbach E., Anhlan D., Ahmann K., Banning C., Reiling S.J., Kuhn J., Strobl S., Vitt D., Leban J., Planz O., Ludwig S. The NF-kappaB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance. Cell. Microbiol. 2013, 15:1198-1211.
82. Jin J., Hu H., Li H.S., Yu J., Xiao Y., Brittain G.C., Zou Q., Cheng X., Mallette F.A., Watowich S.S., Sun S.C. Noncanonical NF-kappaB pathway controls the production of type I interferons in antiviral innate immunity. Immunity 2014, 40:342-354.
83. Kumar N., Xin Z.T., Liang Y., Ly H., Liang Y. NF-kappaB signaling differentially regulates influenza virus RNA synthesis. J. Virol. 2008, 82:9880-9889.
84. Mazur I., Wurzer W.J., Ehrhardt C., Pleschka S., Puthavathana P., Silberzahn T., Wolff T., Planz O., Ludwig S. Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity. Cell. Microbiol. 2007, 9:1683-1694.
85. Pinto R., Herold S., Cakarova L., Hoegner K., Lohmeyer J., Planz O., Pleschka S. Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo. Antiviral Res. 2011, 92:45-56.
86. Nimmerjahn F., Dudziak D., Dirmeier U., Hobom G., Riedel A., Schlee M., Staudt L.M., Rosenwald A., Behrends U., Bornkamm G.W., Mautner J. Active NF-kappaB signalling is a prerequisite for influenza virus infection. J. Gen. Virol. 2004, 85:2347-2356.
87. Wurzer W.J., Ehrhardt C., Pleschka S., Berberich-Siebelt F., Wolff T., Walczak H., Planz O., Ludwig S. NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. J. Biol. Chem. 2004, 279:30931-30937.
88. Schmolke M., Viemann D., Roth J., Ludwig S. Essential impact of NF-kappaB signaling on the H5N1 influenza A virus-induced transcriptome. J. Immunol. 2009, 183:5180-5189.
89. Lupfer C., Thomas P.G., Anand P.K., Vogel P., Milasta S., Martinez J., Huang G., Green M., Kundu M., Chi H., Xavier R.J., Green D.R., Lamkanfi M., Dinarello C.A., Doherty P.C., Kanneganti T.D. Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection. Nat. Immunol. 2013, 14:480-488.
90. Huang D.B., Vu D., Cassiday L.A., Zimmerman J.M., Maher L.J., Ghosh G. Crystal structure of NF-kappaB (p50)2 complexed to a high-affinity RNA aptamer. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:9268-9273.
91. Watanabe T., Watanabe S., Kawaoka Y. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 2010, 7:427-439.
92. Bernasconi D., Amici C., La F.S., Ianaro A., Santoro M.G. The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells. J. Biol. Chem. 2005, 280:24127-24134.
93. Maelfait J., Roose K., Bogaert P., Sze M., Saelens X., Pasparakis M., Carpentier I., van Loo G., Beyaert R. A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infection. PLoS Pathog. 2012, 8:e1002570.
94. Goulet M.L., Olagnier D., Xu Z., Paz S., Belgnaoui S.M., Lafferty E.I., Janelle V., Arguello M., Paquet M., Ghneim K., Richards S., Smith A., Wilkinson P., Cameron M., Kalinke U., Qureshi S., Lamarre A., Haddad E.K., Sekaly R.P., Peri S., Balachandran S., Lin R., Hiscott J. Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity. PLoS Pathog. 2013, 9:e1003298.
95. Tumpey T.M., Garcia-Sastre A., Taubenberger J.K., Palese P., Swayne D.E., Pantin-Jackwood M.J., Schultz-Cherry S., Solorzano A., Van Rooijen N., Katz J.M., Basler C.F. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J. Virol. 2005, 79:14933-14944.
96. Hui K.P., Lee S.M., Cheung C.Y., Mao H., Lai A.K., Chan R.W., Chan M.C., Tu W., Guan Y., Lau Y.L., Peiris J.S. H5N1 influenza virus-induced mediators upregulate RIG-I in uninfected cells by paracrine effects contributing to amplified cytokine cascades. J. Infect. Dis. 2011, 204:1866-1878.
97. Geiss G.K., Salvatore M., Tumpey T.M., Carter V.S., Wang X., Basler C.F., Taubenberger J.K., Bumgarner R.E., Palese P., Katze M.G., Garcia-Sastre A. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:10736-10741.
98. Tisoncik J.R., Billharz R., Burmakina S., Belisle S.E., Proll S.C., Korth M.J., Garcia-Sastre A., Katze M.G. The NS1 protein of influenza A virus suppresses interferon-regulated activation of antigen-presentation and immune-proteasome pathways. J. Gen. Virol. 2011, 92:2093-2104.
99. Gao S., Song L., Li J., Zhang Z., Peng H., Jiang W., Wang Q., Kang T., Chen S., Huang W. Influenza A virus-encoded NS1 virulence factor protein inhibits innate immune response by targeting IKK. Cell. Microbiol. 2012, 14:1849-1866.
100. Rückle A., Haasbach E., Julkunen I., Planz O., Ehrhardt C., Ludwig S. The NS1 protein of influenza A virus blocks RIG-I-mediated activation of the noncanonical NF-kappaB pathway and p52/RelB-dependent gene expression in lung epithelial cells. J. Virol. 2012, 86:10211-10217.
101. Li W., Wang G., Zhang H., Xin G., Zhang D., Zeng J., Chen X., Xu Y., Cui Y., Li K. Effects of NS1 variants of H5N1 influenza virus on interferon induction, TNFalpha response and p53 activity. Cell. Mol. Immunol. 2010, 7:235-242.
102. König R., Stertz S., Zhou Y., Inoue A., Hoffmann H.H., Bhattacharyya S., Alamares J.G., Tscherne D.M., Ortigoza M.B., Liang Y., Gao Q., Andrews S.E., Bandyopadhyay S., De J.P., Tu B.P., Pache L., Shih C., Orth A., Bonamy G., Miraglia L., Ideker T., Garcia-Sastre A., Young J.A., Palese P., Shaw M.L., Chanda S.K. Human host factors required for influenza virus replication. Nature 2010, 463:813-817.
103. Shapira S.D., Gat-Viks I., Shum B.O., Dricot A., de Grace M.M., Wu L., Gupta P.B., Hao T., Silver S.J., Root D.E., Hill D.E., Regev A., Hacohen N. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 2009, 139:1255-1267.
104. Reis A.L., McCauley J.W. The influenza virus protein PB1-F2 interacts with IKKbeta and modulates NF-kappaB signalling. PLoS One 2013, 8:e63852.
105. Le Goffic R., Leymarie O., Chevalier C., Rebours E., Da C.B., Vidic J., Descamps D., Sallenave J.M., Rauch M., Samson M., Delmas B. Transcriptomic analysis of host immune and cell death responses associated with the influenza A virus PB1-F2 protein. PLoS Pathog. 2011, 7:e1002202.
106. Thangavel R.R., Bouvier N.M. Animal models for influenza virus pathogenesis, transmission, and immunology. J. Immunol. Methods 2014, (Apr 4, Epub ahead of print) (Review). 10.1016/j.jim.2014.03.023.
107. Poiesz B.J., Ruscetti F.W., Reitz M.S., Kalyanaraman V.S., Gallo R.C. Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukaemia. Nature 1981, 294:268-271.
108. Haynes B.F., Miller S.E., Palker T.J., Moore J.O., Dunn P.H., Bolognesi D.P., Metzgar R.S. Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis. Proc. Natl. Acad. Sci. U. S. A. 1983, 80:2054-2058.
109. Kalyanaraman V.S., Sarngadharan M.G., Nakao Y., Ito Y., Aoki T., Gallo R.C. Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan. Proc. Natl. Acad. Sci. U. S. A. 1982, 79:1653-1657.
110. Verdonck K., Gonzalez E., Van Dooren S., Vandamme A.M., Vanham G., Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect. Dis. 2007, 7:266-281.
111. Romanelli M.G., Diani E., Bergamo E., Casoli C., Ciminale V., Bex F., Bertazzoni U. Highlights on distinctive structural and functional properties of HTLV Tax proteins. Front. Microbiol. 2013, 4:271.
112. Yamaoka S., Tobe T., Hatanaka M. Tax protein of human T-cell leukemia virus type I is required for maintenance of the transformed phenotype. Oncogene 1992, 7:433-437.
113. Grossman W.J., Kimata J.T., Wong F.H., Zutter M., Ley T.J., Ratner L. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:1057-1061.
114. Nerenberg M., Hinrichs S.H., Reynolds R.K., Khoury G., Jay G. The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science 1987, 237:1324-1329.
115. Boxus M., Twizere J.C., Legros S., Dewulf J.F., Kettmann R., Willems L. The HTLV-1 Tax interactome. Retrovirology 2008, 5:76.
116. Smith M.R., Greene W.C. Characterization of a novel nuclear localization signal in the HTLV-I tax transactivator protein. Virology 1992, 187:316-320.
117. Nejmeddine M., Barnard A.L., Tanaka Y., Taylor G.P., Bangham C.R. Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse. J. Biol. Chem. 2005, 280:29653-29660.
118. Peloponese J.M., Haller K., Miyazato A., Jeang K.T. Abnormal centrosome amplification in cells through the targeting of Ran-binding protein-1 by the human T cell leukemia virus type-1 Tax oncoprotein. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:18974-18979.
119. Ching Y.P., Chan S.F., Jeang K.T., Jin D.Y. The retroviral oncoprotein Tax targets the coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication. Nat. Cell Biol. 2006, 8:717-724.
120. Alefantis T., Mostoller K., Jain P., Harhaj E., Grant C., Wigdahl B. Secretion of the human T cell leukemia virus type I transactivator protein tax. J. Biol. Chem. 2005, 280:17353-17362.
121. Akagi T., Ono H., Nyunoya H., Shimotohno K. Characterization of peripheral blood T-lymphocytes transduced with HTLV-I Tax mutants with different trans-activating phenotypes. Oncogene 1997, 14:2071-2078.
122. Robek M.D., Ratner L. Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J. Virol. 1999, 73:4856-4865.
123. Kitajima I., Shinohara T., Bilakovics J., Brown D.A., Xu X., Nerenberg M. Ablation of transplanted HTLV-I tax-transformed tumors in mice by antisense inhibition of NF-kappa B. Science 1993, 259:1523.
124. Mori N., Yamada Y., Ikeda S., Yamasaki Y., Tsukasaki K., Tanaka Y., Tomonaga M., Yamamoto N., Fujii M. Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 2002, 100:1828-1834.
125. Sanda T., Asamitsu K., Ogura H., Iida S., Utsunomiya A., Ueda R., Okamoto T. Induction of cell death in adult T-cell leukemia cells by a novel IkappaB kinase inhibitor. Leukemia 2006, 20:590-598.
126. Watanabe M., Ohsugi T., Shoda M., Ishida T., Aizawa S., Maruyama-Nagai M., Utsunomiya A., Koga S., Yamada Y., Kamihira S., Okayama A., Kikuchi H., Uozumi K., Yamaguchi K., Higashihara M., Umezawa K., Watanabe T., Horie R. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood 2005, 106:2462-2471.
127. Fu J., Qu Z., Yan P., Ishikawa C., Aqeilan R.I., Rabson A.B., Xiao G. The tumor suppressor gene WWOX links the canonical and noncanonical NF-kappaB pathways in HTLV-I Tax-mediated tumorigenesis. Blood 2011, 117:1652-1661.
128. Koiwa T., Hamano-Usami A., Ishida T., Okayama A., Yamaguchi K., Kamihira S., Watanabe T. 5'-Long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J. Virol. 2002, 76:9389-9397.
129. Takeda S., Maeda M., Morikawa S., Taniguchi Y., Yasunaga J., Nosaka K., Tanaka Y., Matsuoka M. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int. J. Cancer 2004, 109:559-567.
130. Taniguchi Y., Nosaka K., Yasunaga J., Maeda M., Mueller N., Okayama A., Matsuoka M. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology 2005, 2:64.
131. Hironaka N., Mochida K., Mori N., Maeda M., Yamamoto N., Yamaoka S. Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells. Neoplasia 2004, 6:266-278.
132. Mori N., Fujii M., Ikeda S., Yamada Y., Tomonaga M., Ballard D.W., Yamamoto N. Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood 1999, 93:2360-2368.
133. Vlantis K., Wullaert A., Sasaki Y., Schmidt-Supprian M., Rajewsky K., Roskams T., Pasparakis M. Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice. J. Clin. Invest. 2011, 121:2781-2793.
134. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., Kirk H.E., Kay R.J., Israel A. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 1998, 93:1231-1240.
135. Chu Z.L., Shin Y.A., Yang J.M., DiDonato J.A., Ballard D.W. IKKgamma mediates the interaction of cellular IkappaB kinases with the tax transforming protein of human T cell leukemia virus type 1. J. Biol. Chem. 1999, 274:15297-15300.
136. Harhaj E.W., Sun S.C. IKKgamma serves as a docking subunit of the IkappaB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J. Biol. Chem. 1999, 274:22911-22914.
137. Jin D.Y., Giordano V., Kibler K.V., Nakano H., Jeang K.T. Role of adapter function in oncoprotein-mediated activation of NF-kappaB. Human T-cell leukemia virus type I Tax interacts directly with IkappaB kinase gamma. J. Biol. Chem. 1999, 274:17402-17405.
138. Huang J., Ren T., Guan H., Jiang Y., Cheng H. HTLV-1 Tax is a critical lipid raft modulator that hijacks IkappaB kinases to the microdomains for persistent activation of NF-kappaB. J. Biol. Chem. 2009, 284:6208-6217.
139. Lamsoul I., Lodewick J., Lebrun S., Brasseur R., Burny A., Gaynor R.B., Bex F. Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein. Mol. Cell. Biol. 2005, 25:10391-10406.
140. Chen Z.J., Sun L.J. Nonproteolytic functions of ubiquitin in cell signaling. Mol. Cell 2009, 33:275-286.
141. Kensche T., Tokunaga F., Ikeda F., Goto E., Iwai K., Dikic I. Analysis of nuclear factor-kappaB (NF-kappaB) essential modulator (NEMO) binding to linear and lysine-linked ubiquitin chains and its role in the activation of NF-kappaB. J. Biol. Chem. 2012, 287:23626-23634.
142. Hadian K., Griesbach R.A., Dornauer S., Wanger T.M., Nagel D., Metlitzky M., Beisker W., Schmidt-Supprian M., Krappmann D. NF-kappaB essential modulator (NEMO) interaction with linear and lys-63 ubiquitin chains contributes to NF-kappaB activation. J. Biol. Chem. 2011, 286:26107-26117.
143. Shembade N., Harhaj N.S., Yamamoto M., Akira S., Harhaj E.W. The human T-cell leukemia virus type 1 Tax oncoprotein requires the ubiquitin-conjugating enzyme Ubc13 for NF-kappaB activation. J. Virol. 2007, 81:13735-13742.
144. Deng L., Wang C., Spencer E., Yang L., Braun A., You J., Slaughter C., Pickart C., Chen Z.J. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000, 103:351-361.
145. Yasunaga J., Lin F.C., Lu X., Jeang K.T. Ubiquitin-specific peptidase 20 targets TRAF6 and human T cell leukemia virus type 1 tax to negatively regulate NF-kappaB signaling. J. Virol. 2011, 85:6212-6219.
146. Lavorgna A., Harhaj E.W. An RNA interference screen identifies the deubiquitinase STAMBPL1 as a critical regulator of human T-cell leukemia virus type 1 tax nuclear export and NF-kappaB activation. J. Virol. 2012, 86:3357-3369.
147. Journo C., Filipe J., About F., Chevalier S.A., Afonso P.V., Brady J.N., Flynn D., Tangy F., Israel A., Vidalain P.O., Mahieux R., Weil R. NRP/Optineurin cooperates with TAX1BP1 to potentiate the activation of NF-kappaB by human T-lymphotropic virus type 1 tax protein. PLoS Pathog. 2009, 5:e1000521.
148. Semmes O.J., Jeang K.T. Localization of human T-cell leukemia virus type 1 tax to subnuclear compartments that overlap with interchromatin speckles. J. Virol. 1996, 70:6347-6357.
149. Bex F., McDowall A., Burny A., Gaynor R. The human T-cell leukemia virus type 1 transactivator protein Tax colocalizes in unique nuclear structures with NF-kappaB proteins. J. Virol. 1997, 71:3484-3497.
150. Wu X., Qi J., Bradner J.E., Xiao G., Chen L.F. Bromodomain and extraterminal (BET) protein inhibition suppresses human T cell leukemia virus 1 (HTLV-1) Tax protein-mediated tumorigenesis by inhibiting nuclear factor kappaB (NF-kappaB) signaling. J. Biol. Chem. 2013, 288:36094-36105.
151. Xiao G., Cvijic M.E., Fong A., Harhaj E.W., Uhlik M.T., Waterfield M., Sun S.C. Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha. EMBO J. 2001, 20:6805-6815.
152. Shinkura R., Kitada K., Matsuda F., Tashiro K., Ikuta K., Suzuki M., Kogishi K., Serikawa T., Honjo T. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. Nat. Genet. 1999, 22:74-77.
153. Nitta T., Tanaka M., Sun B., Sugihara E., Kimura M., Kamada Y., Takahashi H., Hanai S., Jiang S.W., Fujisawa J., Miwa M. Reduction of human T-cell leukemia virus type-1 infection in mice lacking nuclear factor-kappaB-inducing kinase. Cancer Sci. 2008, 99:872-878.
154. Liao G., Zhang M., Harhaj E.W., Sun S.C. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 2004, 279:26243-26250.
155. Yamagishi M., Nakano K., Miyake A., Yamochi T., Kagami Y., Tsutsumi A., Matsuda Y., Sato-Otsubo A., Muto S., Utsunomiya A., Yamaguchi K., Uchimaru K., Ogawa S., Watanabe T. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell 2012, 21:121-135.
156. Renner F., Schmitz M.L. Autoregulatory feedback loops terminating the NF-kappaB response. Trends Biochem. Sci. 2009, 34:128-135.
157. Schmitz M.L., Weber A., Roxlau T., Gaestel M., Kracht M. Signal integration, crosstalk mechanisms and networks in the function of inflammatory cytokines. Biochim. Biophys. Acta 2011, 1813:2165-2175.
158. Baydoun H.H., Bai X.T., Shelton S., Nicot C. HTLV-I tax increases genetic instability by inducing DNA double strand breaks during DNA replication and switching repair to NHEJ. PLoS One 2012, 7:e42226.
159. Majone F., Jeang K.T. Unstabilized DNA breaks in HTLV-1 Tax expressing cells correlate with functional targeting of Ku80, not PKcs, XRCC4, or H2AX. Cell Biosci. 2012, 2:15.
160. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
161. Gao L., Harhaj E.W. HSP90 protects the human T-cell leukemia virus type 1 (HTLV-1) tax oncoprotein from proteasomal degradation to support NF-kappaB activation and HTLV-1 replication. J. Virol. 2013, 87:13640-13654.
162. Peloponese J.M., Yasunaga J., Kinjo T., Watashi K., Jeang K.T. Peptidylproline cis-trans-isomerase Pin1 interacts with human T-cell leukemia virus type 1 tax and modulates its activation of NF-kappaB. J. Virol. 2009, 83:3238-3248.